P

Inventor

ROTHE CHRISTINE

DE26 patents
⚠️ This page may combine multiple inventors who share the name “ROTHE CHRISTINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PIERIS PHARMACEUTICALS GMBH

14 patents
US10526382B2Jan 7, 2020

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

PIERIS PHARMACEUTICALS GMBH6 citations82
US11261221B2Mar 1, 2022

Proteins specific for CD137

PIERIS PHARMACEUTICALS GMBH2 citations72
US10501510B2Dec 10, 2019

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

PIERIS PHARMACEUTICALS GMBH4 citations71
US10400016B2Sep 3, 2019

Proteins specific for calcitonin gene-related peptide

PIERIS PHARMACEUTICALS GMBH4 citations71
US12195503B2Jan 14, 2025

Proteins specific for CD137

PIERIS PHARMACEUTICALS GMBH0 citations62
US11034737B2Jun 15, 2021

Proteins specific for calcitonin gene-related peptide

PIERIS PHARMACEUTICALS GMBH1 citations61
US11034738B2Jun 15, 2021

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

PIERIS PHARMACEUTICALS GMBH0 citations61
US10927156B2Feb 23, 2021

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

PIERIS PHARMACEUTICALS GMBH1 citations61
US11919931B2Mar 5, 2024

Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)

PIERIS PHARMACEUTICALS GMBH1 citations60
US10913778B2Feb 9, 2021

Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides

PIERIS PHARMACEUTICALS GMBH1 citations60
US11773147B2Oct 3, 2023

Lipocalin muteins with binding affinity for LAG-3

PIERIS PHARMACEUTICALS GMBH1 citations59
US11168119B2Nov 9, 2021

Lipocalin muteins with binding affinity for LAG-3

PIERIS PHARMACEUTICALS GMBH1 citations59
US10947284B2Mar 16, 2021

Fusion molecules

PIERIS PHARMACEUTICALS GMBH1 citations59
US10865250B2Dec 15, 2020

Anti-cancer fusion polypeptide

PIERIS PHARMACEUTICALS GMBH1 citations58

SANOFI SA

6 patents

BARDROFF MICHAEL

2 patents

HOFFMANN LA ROCHE

1 patent

DAIICHI SANKYO CO LTD

1 patent

PIERIS AG

1 patent

ENZELBERGER MARKUS

1 patent